Evaluation of a specific diagnostic marker for rheumatoid arthritis based on cyclic citrullinated peptide

Min Park, Jae Chul Pyun, Hafeza Akter, Binh Thanh Nguyen, Min Jung Kang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

A specific peptide marker for diagnosing rheumatoid arthritis (RA) was found based on cyclic citrullinated peptide (CCP) using the following three steps: (1) analysis of the binding epitope of autoimmune antibodies using ε-aminocaproic acid-modified peptides; (2) RA diagnosis using sequence-modified peptides; and (3) evaluation of the peptides' diagnostic performance for RA diagnosis. Ninety-five serum samples were analyzed by ELISA and compared using MedCalc (version 15.2.1). Microplate binding ε-aminocaproic acid was added to the N- or C-terminal of the CCP sequence. The N-terminal anchoring peptide assay showed 15% higher specificity compared with the C-terminal anchoring peptide assay. Based on this result, the hydrophilic C-terminal sequence of CCP was substituted with a hydrophobic amino acid. Among the sequence-modified peptides, CCP11A (in which alanine was substituted for the 11th amino acid of CCP) assay showed the highest sensitivity (87%) and specificity (100%) for RA diagnosis. Thus, CCP11A was selected as a possible specific marker peptide for RA diagnosis and further analyzed. The results of this analysis indicated that CCP11A showed better specificity than the CCP assay in both healthy individuals (11% better) and OA cohort (20% better). From these results, CCP11A was evaluated as a specific marker for diagnosing RA with higher diagnostic performance.

Original languageEnglish
Pages (from-to)107-113
Number of pages7
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume115
DOIs
Publication statusPublished - 2015 Nov 1

Fingerprint

Rheumatoid Arthritis
Peptides
Assays
Aminocaproic Acid
Amino Acids
cyclic citrullinated peptide
Alanine
Amino acids
Epitopes
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity
Antibodies
Serum

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Pharmaceutical Science
  • Drug Discovery
  • Spectroscopy
  • Clinical Biochemistry

Cite this

@article{682ef0749843454eb158b134604f1517,
title = "Evaluation of a specific diagnostic marker for rheumatoid arthritis based on cyclic citrullinated peptide",
abstract = "A specific peptide marker for diagnosing rheumatoid arthritis (RA) was found based on cyclic citrullinated peptide (CCP) using the following three steps: (1) analysis of the binding epitope of autoimmune antibodies using ε-aminocaproic acid-modified peptides; (2) RA diagnosis using sequence-modified peptides; and (3) evaluation of the peptides' diagnostic performance for RA diagnosis. Ninety-five serum samples were analyzed by ELISA and compared using MedCalc (version 15.2.1). Microplate binding ε-aminocaproic acid was added to the N- or C-terminal of the CCP sequence. The N-terminal anchoring peptide assay showed 15{\%} higher specificity compared with the C-terminal anchoring peptide assay. Based on this result, the hydrophilic C-terminal sequence of CCP was substituted with a hydrophobic amino acid. Among the sequence-modified peptides, CCP11A (in which alanine was substituted for the 11th amino acid of CCP) assay showed the highest sensitivity (87{\%}) and specificity (100{\%}) for RA diagnosis. Thus, CCP11A was selected as a possible specific marker peptide for RA diagnosis and further analyzed. The results of this analysis indicated that CCP11A showed better specificity than the CCP assay in both healthy individuals (11{\%} better) and OA cohort (20{\%} better). From these results, CCP11A was evaluated as a specific marker for diagnosing RA with higher diagnostic performance.",
author = "Min Park and Pyun, {Jae Chul} and Hafeza Akter and Nguyen, {Binh Thanh} and Kang, {Min Jung}",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.jpba.2015.06.032",
language = "English",
volume = "115",
pages = "107--113",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",

}

Evaluation of a specific diagnostic marker for rheumatoid arthritis based on cyclic citrullinated peptide. / Park, Min; Pyun, Jae Chul; Akter, Hafeza; Nguyen, Binh Thanh; Kang, Min Jung.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 115, 01.11.2015, p. 107-113.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of a specific diagnostic marker for rheumatoid arthritis based on cyclic citrullinated peptide

AU - Park, Min

AU - Pyun, Jae Chul

AU - Akter, Hafeza

AU - Nguyen, Binh Thanh

AU - Kang, Min Jung

PY - 2015/11/1

Y1 - 2015/11/1

N2 - A specific peptide marker for diagnosing rheumatoid arthritis (RA) was found based on cyclic citrullinated peptide (CCP) using the following three steps: (1) analysis of the binding epitope of autoimmune antibodies using ε-aminocaproic acid-modified peptides; (2) RA diagnosis using sequence-modified peptides; and (3) evaluation of the peptides' diagnostic performance for RA diagnosis. Ninety-five serum samples were analyzed by ELISA and compared using MedCalc (version 15.2.1). Microplate binding ε-aminocaproic acid was added to the N- or C-terminal of the CCP sequence. The N-terminal anchoring peptide assay showed 15% higher specificity compared with the C-terminal anchoring peptide assay. Based on this result, the hydrophilic C-terminal sequence of CCP was substituted with a hydrophobic amino acid. Among the sequence-modified peptides, CCP11A (in which alanine was substituted for the 11th amino acid of CCP) assay showed the highest sensitivity (87%) and specificity (100%) for RA diagnosis. Thus, CCP11A was selected as a possible specific marker peptide for RA diagnosis and further analyzed. The results of this analysis indicated that CCP11A showed better specificity than the CCP assay in both healthy individuals (11% better) and OA cohort (20% better). From these results, CCP11A was evaluated as a specific marker for diagnosing RA with higher diagnostic performance.

AB - A specific peptide marker for diagnosing rheumatoid arthritis (RA) was found based on cyclic citrullinated peptide (CCP) using the following three steps: (1) analysis of the binding epitope of autoimmune antibodies using ε-aminocaproic acid-modified peptides; (2) RA diagnosis using sequence-modified peptides; and (3) evaluation of the peptides' diagnostic performance for RA diagnosis. Ninety-five serum samples were analyzed by ELISA and compared using MedCalc (version 15.2.1). Microplate binding ε-aminocaproic acid was added to the N- or C-terminal of the CCP sequence. The N-terminal anchoring peptide assay showed 15% higher specificity compared with the C-terminal anchoring peptide assay. Based on this result, the hydrophilic C-terminal sequence of CCP was substituted with a hydrophobic amino acid. Among the sequence-modified peptides, CCP11A (in which alanine was substituted for the 11th amino acid of CCP) assay showed the highest sensitivity (87%) and specificity (100%) for RA diagnosis. Thus, CCP11A was selected as a possible specific marker peptide for RA diagnosis and further analyzed. The results of this analysis indicated that CCP11A showed better specificity than the CCP assay in both healthy individuals (11% better) and OA cohort (20% better). From these results, CCP11A was evaluated as a specific marker for diagnosing RA with higher diagnostic performance.

UR - http://www.scopus.com/inward/record.url?scp=84938572883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938572883&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2015.06.032

DO - 10.1016/j.jpba.2015.06.032

M3 - Article

VL - 115

SP - 107

EP - 113

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

ER -